Coherus BioSciences, Inc. IPO Research Information

Coherus BioSciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Coherus BioSciences, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Coherus BioSciences, Inc.	CHRS - NASDAQ	$12.00-$15.00	$13.50	$12.75	6.3 million	11/6/2014
Underwriter(s): J.P. Morgan, Credit Suisse
Co-Manager(s): Cowen & Co.
Industry: Health Care
Filing(s): Filed 2014-09-25 Terms Added 2014-10-24

Coherus BioSciences, Inc. Quote & Chart - Click for current quote - CHRS

About Coherus BioSciences, Inc. (adapted from Coherus BioSciences, Inc. prospectus):
They are a late-stage clinical biologics platform company focused on the global biosimilar market.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CHRS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.